MEDEC expects new, progressive policy on e-labelling
This article was originally published in RAJ Devices
The Canadian medical device industry association, MEDEC, is hopeful that Health Canada will take a more "progressive and flexible stance" on the issue of e-labelling as most major markets are already moving ahead with the concept in their respective jurisdictions. MEDEC expects the Canadian regulator to address the issue through a policy notice later this year1.
You may also be interested in...
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.